Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of LI [Multikine®] Plus SOC (Surgery + Radiotherapy or Surgery + Concurrent Radiochemotherapy) in Subjects With Advanced Primary Squamous Cell Carcinoma of the Oral Cavity/Soft Palate vs. SOC Only

NCT01265849 is registered in ClinicalTrials.gov with CEL-SCI Corporation as lead sponsor.

NCT NCT01265849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01265849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of LI [Multikine®] Plus SOC (Surgery + Radiotherapy or Surgery + Concurrent Radiochemotherapy) in Subjects With Advanced Primary Squamous Cell Carcinoma of the Oral Cavity/Soft Palate vs. SOC Only
Lead sponsor
CEL-SCI Corporation
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2010
Completion date
December 4, 2020
Enrollment
928 (actual)
Sites
102

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the oral cavity, squamous cell carcinoma of the soft palate